Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6527
    +0.0009 (+0.14%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin AUD

    107,399.00
    -2,190.89 (-2.00%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6043
    +0.0009 (+0.14%)
     
  • AUD/NZD

    1.0906
    +0.0004 (+0.03%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     

Midday movers: Activision Blizzard, Oneok, Newmont and more

Investing.com -- Stocks were headed higher as investors await clarity on the outcome of debt ceiling negotiations in Washington. Here are the market movers for May 15.

Activision Blizzard Inc (NASDAQ:ATVI) stock rose 1% after European Union regulators approved Microsoft's $69 billion acquisition of the video game maker. Microsoft Corporation (NASDAQ:MSFT)shares were flat. ONEOK Inc (NYSE:OKE) shares fell 8.5% after it announced a deal for Magellan Midstream Partners LP (NYSE:MMP) for $18.8B. Magellan shares rose 13%. The deal will create one of the largest companies engaged in the transfer of oil and gas. Newmont Goldcorp Corp (NYSE:NEM) shares rose 1.8% after the mining giant struck a $17.5B deal for Australia's Newcrest Mining (OTC:NCMGF) (ASX:NCM) to great the world's biggest gold mining company. Newcrest shares rose 2%. H&R Block Inc (NYSE:HRB) shares fell 3.7% and shares of Intuit Inc (NASDAQ:INTU) fell 1.3% after reports the federal government is looking at offering a free electronic filing platform for taxpayers directly to the Internal Revenue Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares jumped 28% after expert outside advisors to the Food and Drug Administration recommended approval for its muscular dystrophy gene therapy.

Related Articles

Midday movers: Activision Blizzard, Oneok, Newmont and more

ONEOK shares drop on concerns over Magellan pipeline deal

Musk tells Tesla staff he must approve all hiring - the Information